Home » MorphoSys, Bristol-Myers Squibb Extend Cooperation
MorphoSys, Bristol-Myers Squibb Extend Cooperation
German biotech MorphoSys AG is expanding its existing license agreement with Bristol-Myers Squibb. Under the amended agreement, MorphoSys grants Bristol-Myers Squibb access to its HuCAL GOLD library for use in Bristol-Myers Squibb's pharmaceutical discovery programs for target characterization and validation, as well as for therapeutic and diagnostic antibody product development. Financial details were not disclosed.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May